Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemical Tools for the Study of DNA Repair. | Acc Chem Res | 2022 | 36355579 | PubTator, text mining | PubMed |
| Recent Advances on DNA Base Flipping: A General Mechanism for Writing, Reading, and Erasing DNA Modifications. | Adv Exp Med Biol | 2022 | 36350515 | PubTator, text mining | PubMed |
| Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. | Nat Commun | 2022 | 36344544 | PubTator, text mining | PubMed |
| Integrated proteogenomic characterization of medullary thyroid carcinoma. | Cell Discov | 2022 | 36344509 | PubTator, text mining | PubMed |
| Associations of DNA Base Excision Repair and Antioxidant Enzyme Genetic Risk Scores with Biomarker of Systemic Inflammation. | Front Aging | 2022 | 36338835 | PubTator, text mining | PubMed |
| Systems biology and OMIC data integration to understand gastrointestinal cancers. | World J Clin Oncol | 2022 | 36337313 | PubTator, text mining | PubMed |
| Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma. | Sci Rep | 2022 | 36335135 | PubTator, text mining | PubMed |
| Whole blood methylome-derived features to discriminate endocrine hypertension. | Clin Epigenetics | 2022 | 36329530 | PubTator, text mining | PubMed |
| Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service. | Sci Rep | 2022 | 36329109 | PubTator, text mining | PubMed |
| Hereditary variants of unknown significance in African American women with breast cancer. | PLoS One | 2022 | 36315513 | PubTator, text mining | PubMed |
| The two faces of DNA oxidation in genomic and functional mosaicism during aging in human neurons. | Front Aging | 2022 | 36313183 | PubTator, text mining | PubMed |
| Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma. | Cold Spring Harb Mol Case Stud | 2022 | 36307212 | PubTator, text mining | PubMed |
| Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36305726 | PubTator, text mining | PubMed |
| The role of UV-DDB in processing 8-oxoguanine during base excision repair. | Biochem Soc Trans | 2022 | 36305644 | PubTator, text mining | PubMed |
| What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. | Cancer | 2022 | 36305018 | PubTator, text mining | PubMed |
| Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in BRCA and in Other Susceptibility Genes. | Genes (Basel) | 2022 | 36292577 | PubTator, text mining | PubMed |
| Teenage-Onset Colorectal Cancers in a Digenic Cancer Predisposition Syndrome Provide Clues for the Interaction between Mismatch Repair and Polymerase δ Proofreading Deficiency in Tumorigenesis. | Biomolecules | 2022 | 36291559 | PubTator, text mining | PubMed |
| Distinct Mechanisms of Target Search by Endonuclease VIII-like DNA Glycosylases. | Cells | 2022 | 36291061 | PubTator, text mining | PubMed |
| Application of Multigene Panels Testing for Hereditary Cancer Syndromes. | Biology (Basel) | 2022 | 36290365 | PubTator, text mining | PubMed |
| Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients. | Cancer Control | 2022 | 36283420 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=36